Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022

BUY
$224.46 - $253.15 $3,591 - $4,050
16 New
16 $4,000
Q1 2019

May 07, 2019

SELL
$180.87 - $203.88 $1,989 - $2,242
-11 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $1,962 - $2,290
11 New
11 $2,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Karp Capital Management Corp Portfolio

Follow Karp Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karp Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Karp Capital Management Corp with notifications on news.